In the nucleus of cancer cells, HAR1A functioned upstream of the signaling pathway, and knockdown of HAR1A promoted ALPK1 expression and downregulated myosin IIA and BRD7, leading to inflammation and oral cancer progression. This evidence concerns the gene BRD7 and lip and oral cavity carcinoma.